Article
Clinical grade ACE2 effectively inhibits SARS-CoV-2 Omicron infections
2021-12-27
Abstract excerpt
The recent emergence of the SARS-CoV-2 variant Omicron has caused considerable concern due to reduced vaccine efficacy and escape from neutralizing antibody therapeutics. Omicron is spreading rapidly around the globe and is suspected to account for most new COVID-19 cases in several countries, though the severity of Omicron-mediated disease is still under debate. It is therefore paramount to identify therapeutic s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fd47c8cc-d874-5801-a2b6-122c21b02900
- DOI
- 10.1101/2021.12.25.474113
